189365-92-2

Basic information

• Product Name: Benzoic acid, 4-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)-
• CAS NO: 189365-92-2
• Molecular Formula: C9H6N2O4
• Molecular Weight: 206.158
• Mol File: 189365-92-2.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 4-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 4-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)-(189365-92-2)
• EPA Substance Registry System: Benzoic acid, 4-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)-(189365-92-2)

Safety Data

• Hazardous Substances Data: 189365-92-2(Hazardous Substances Data)

Upstream product

• 1444001-63-1 ethyl 4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)benzoate 
• 1444001-62-0 ethyl 4-(N'-((ethoxycarbonyl)oxy)carbamimidoyl)benzoate 
• 1227154-44-0 ethyl 4-(N'-hydroxycarbamimidoyl)benzoate 
• 7153-22-2 ethyl 4-cyanobenzoate 
• 184778-33-4 methyl (Z)-4-(N’-hydroxycarbamimidoyl)benzoate 
• 1129-35-7 4-cyanobenzoic acid methyl ester 
• 281234-03-5 methyl 4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)benzoate 

Downstream Products

• 340736-41-6 methyl 2-[(2S)-4-[2-(tert-butoxy)-2-oxoethyl]-1-[(2S)-3-(4-methoxyphenyl)-2-[[4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)benzoyl]amino]propanoyl]-3-oxopiperazinyl]acetate 
• 847671-80-1 ethyl 5-(7-{[4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)benzoyl]amino}-2H-1,4-benzoxazin-3(4H)-on-4-yl)pentanoate 
• 847671-55-0 ethyl (2S)-2-{[(2,4-dimethyl-7-{[4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)benzoyl]amino}-2H-1,4-benzoxazin-3(4H)-on-2-yl)carbonyl]amino}-3-{[(4-methylphenyl)sulphonyl]amino}propanoate 
• 1444001-08-4 (S)-ethyl 1-(4-(2-oxo-5-((4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)benzamido)methyl)oxazolidin-3-yl)phenyl)piperidine-4-carboxylate 
• 1413286-13-1 C₂₅H₂₆Cl₂N₄O₄ 

Relevant articles and documents

FACTOR XIa INHIBITORS

The present invention provides a compound of Formula (I) and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing thromboses, embolisms, hypercoagulability or fibrotic changes. The compounds are selective Factor XIa inhibitors or dual inhibitors of Factor XIa and plasma kallikrein.

MODULATORS OF ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTORS AND THERAPEUTIC USES THEREOF

The present invention relates to compounds with α7 nAChR agonistic activity, processes for their preparation, pharmaceutical compositions containing the same and the use thereof for the treatment of neurological, psychiatric, cognitive, immunological and inflammatory disorders.